A carregar...
The use of novel agents in multiple myeloma patients with hepatic impairment
Novel drugs such as immunomodulators and proteasome inhibitors have improved the survival of patients with multiple myeloma. Like all therapeutic agents, appropriate dosing based on metabolism and clearance is important to maintain efficacy while avoiding toxicity. Hepatic impairment (HI) in multipl...
Na minha lista:
| Publicado no: | Future Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361819/ https://ncbi.nlm.nih.gov/pubmed/25675129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.270 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|